New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 26, 2014
07:22 EDTEBS, RPTP, OVAS, DRTX, EGLT, CORTJanney Capital to hold a conference
2nd Annual Healthcare 1x1 Corporate Access Day to be held in Boston on June 26.
News For RPTP;CORT;DRTX;EBS;EGLT;OVAS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 25, 2015
10:22 EDTRPTPOptions with decreasing implied volatility
Subscribe for More Information
November 24, 2015
16:03 EDTEBSEmergent BioSolutions reports FDA approval of BioThrax
Subscribe for More Information
November 23, 2015
18:01 EDTEBSFDA approves new indication for BioThrax
The U.S. FDA approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure. BioThrax is manufactured by Emergent BioDefense Operations Lansing, based in Lansing, Michigan. Reference Link
November 13, 2015
08:28 EDTRPTPAmerican Association for Study of Liver Diseases to hold annual meeting
The Liver Meeting 2015 is being held in San Francisco on November 13-17.
November 12, 2015
06:06 EDTEGLTEgalet announces issuance of U.S. patent covering Guardian Technology
Egalet announced the issuance of a patent by the U.S. Patent and Trademark Office, or USPTO, covering products employing Egalet's Guardian Technology. U.S. patent number U.S. 9,168,228 titled "Pharmaceutical Compositions Resistant to Abuse" was issued October 27.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use